Compensating Participants in Clinical Research: Current thinking

By WIRB-Copernicus Group
Published: November 2017

Sponsors, researches and IRBs are often wary about payments in research participation, citing concerns about coercion and undue influence, whether real or perceived, and have avoided payments that are “too high.” But new research brings a new perspective—are payments to participants actually too low? This paper explores this question and whether there should be less concern about restricting compensation for research participants.

 

Please enter in your information below. Fields with an * are required.

Please enter a valid email address to receive an email with a link to download the white paper.   

The WIRB-Copernicus Group® (WCG) is the world’s largest and most trusted provider of regulatory and ethical review services for human research.